References
- Razay G , Vreugdenhil A, Wilcock G. The metabolic syndrome and alzheimer disease. Arch Neurol 2007;64:93-96. https://doi.org/10.1001/archneur.64.1.93
- Arvanitakis Z, Wilson RS, Bienias JL, Evans DA, Bennett DA. Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function. Arch Neurol 2004;61:661-666. https://doi.org/10.1001/archneur.61.5.661
- Heron DS, Shinitzky M, Hershkowitz M, Samuel D. Lipid fluidity markedly modulates the binding of serotonin to mouse brain membranes. Proc Natl Acad Sci U S A 1980;77:7463-7467. https://doi.org/10.1073/pnas.77.12.7463
- Ballmaier M, Toga AW, Blanton RE, Sowell ER, Lavretsky H, Peterson J, et al. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 2004;161:99-108. https://doi.org/10.1176/appi.ajp.161.1.99
- Eckert GP, Cairns NJ, Maras A, Gattaz WF, Muller WE. Cholesterol modulates the membrane-disordering effects of beta-amyloid peptides in the hippocampus: specific changes in Alzheimer's disease. Dement Geriatr Cogn Disord 2000;11:181-186. https://doi.org/10.1159/000017234
- Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, et al. Midlife vascular ria¨ sk factors and late-life mild cognitive impairment: A poa¨ pulation-based study. Neurology 2001;56:1683-1689. https://doi.org/10.1212/WNL.56.12.1683
- Romas SN, Tang MX, Berglund L, Mayeux R. APOE genotype, plasma lipids, lipoproteins, and AD in community elderly. Neurology 1999;53:517-521. https://doi.org/10.1212/WNL.53.3.517
- Partonen T, Haukka J, Virtamo J, Taylor PR, Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. British Journal of Psychiatry 1999;175:259-262. https://doi.org/10.1192/bjp.175.3.259
- Colin A, Reggers J, Castronovo V, Ansseau M. [Lipids, depression and suicide]. Encephale 2003;29:49-58.
- Tanskanen A, Vartiainen E, Tuomilehto J, Viinamaki H, Lehtonen J, Puska P. High serum cholesterol and risk of suicide. Am J Psychiatry 2000;157:648-650. https://doi.org/10.1176/appi.ajp.157.4.648
- McCallum J, Simons L, Simons J, Friedlander Y. Low serum cholesterol is not associated with depression in the elderly: data from an Australian community study. Australian and New Zealand Journal of Medicine 1994;24:561-564. https://doi.org/10.1111/j.1445-5994.1994.tb01758.x
- Reuben DB, Ix JH, Greendale GA, Seeman TE. The predictive value of combined hypoalbuminemia and hypocholesterolemia in high functioning community-dwelling older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 1999;47:402-406.
- Kim JE, Shin DH, Yoon SW, Baek JH, Jeon DW, Moon JJ, et al. Risk factors for suicide and depression in the elderly over sixty years of age. J Korean Soc Biol Ther Psychiatry 2010;16:46-53.
- Jung IK, Kwak DI, Shin DK, Lee MS, Lee HS, Kim JY. A reliabilty and validity study of geriatric depression scale. J Korean Neuropsychiatr Assoc 1997;36:103-112.
- Beck AT, Kovacs M, Weissman A. Assessment of suicidal intention: the Scale for Suicide Ideation. J Consult Clin Psychol 1979;47:343-352. https://doi.org/10.1037/0022-006X.47.2.343
- Shin MS, Park KB, Oh KJ, Kim ZS. A study of sticidal ideation among high school students: the stuctural relation among depression, hopelessness, and suicidal ideation. Korean J Clin Psychol 1990;9:1-19. https://doi.org/10.1521/jscp.1990.9.1.1
- Koenig HG, Meador KG, Cohen HJ, Blazer DG. Selfrated depression scales and screening for major depression in the older hospitalized patient with medical illness. J Am Geriatr Soc 1988;36:699-706. https://doi.org/10.1111/j.1532-5415.1988.tb07171.x
- McGivney SA, Mulvihill M, Taylor B. Validating the GDS depression screen in the nursing home. J Am Geriatr Soc 1994;42:490-492. https://doi.org/10.1111/j.1532-5415.1994.tb04969.x
- Hachinski VC, Iliff LD, Zilhka E, Du Boulay GH, Mc- Allister VL, Marshall J, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-637. https://doi.org/10.1001/archneur.1975.00490510088009
- Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572. https://doi.org/10.1192/bjp.140.6.566
- Gabryelewicz T, Styczynska M, Luczywek E, Barczak A, Pfeffer A, Androsiulc W, et al. The rate of conversion of mild cognitive impairment to dementia: predictive role of depression. Int J Geriatr Psychiatry 2007;22:563-567. https://doi.org/10.1002/gps.1716
- Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006;63:273-279. https://doi.org/10.1001/archpsyc.63.3.273
- Reuben DB, Ix JH, Greendale GA, Seeman TE. The predictive value of combined hypoalbuminemia and hypocholestrolemia in high functioning community-dwelling older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc 1999;47:402-406.
- Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, et al. Midlife vascular risk factors and late-life mild cognitive impairment: A population- based study. Neurology 2001;56:1683-1689. https://doi.org/10.1212/WNL.56.12.1683
- Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002;59:378-384. https://doi.org/10.1001/archneur.59.3.378
- Notkola IL, Sulkava R, Pekkanen J, Erkinjuntti T, Ehnholm C, Kivinen P, et al. Serum total cholesterol, apolipoprotein E epsilon 4 allele, and Alzheimer's disease. Neuroepidemiology 1998;17:14-20. https://doi.org/10.1159/000026149
- Evans RM, Emsley CL, Gao S, Sahota A, Hall KS, Farlow MR, et al. Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans. Neurology 2000;54:240-242. https://doi.org/10.1212/WNL.54.1.240
- Merched A, Xia Y, Visvikis S, Serot JM, Siest G . Decreased high-density lipoprotein cholesterol and serum apolipoprotein AI concentrations are highly correlated with the severity of Alzheimer's disease. Neurobiol Aging 2000;21:27-30.
- Ward MA, Bendlin BB, McLaren DG , Hess TM, Gallagher CL, Kastman EK, et al. Low HDL Cholesterol is Associated with Lower Gray Matter Volume in Cognitively Healthy Adults. Front Aging Neurosci 2010;2.pii:29.
- Singh-Manoux A, Gimeno D, Kivimaki M, Brunner E, Marmot MG. Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study. Arterioscler Thromb Vasc Biol 2008;28:1418-1420. https://doi.org/10.1161/ATVBAHA.108.169714
- Michikawa M. Cholesterol paradox: is high total or low HDL cholesterol level a risk for Alzheimer's disease? J Neurosci Res 2003;72:141-146. https://doi.org/10.1002/jnr.10585
- Olesen OF, Dago L. High density lipoprotein inhibits assembly of amyloid beta-peptides into fibrils. Biochem Biophys Res Commun 2000;270:62-66. https://doi.org/10.1006/bbrc.2000.2372
- Reiss AB, Siller KA, Rahman MM, Chan ES, Ghiso J, de Leon MJ. Cholesterol in neurologic disorders of the elderly: stroke and Alzheimer's disease. Neurobiol Aging 2004;25:977-989. https://doi.org/10.1016/j.neurobiolaging.2003.11.009
- Cockerill GW, Huehns TY, Weerasinghe A, Stocker C, Lerch PG, Miller NE, et al. Elevation of plasma highdensity lipoprotein concentration reduces interleukin-1- induced expression of E-selectin in an in vivo model of acute inflammation. Circulation 2001;103:108-112. https://doi.org/10.1161/01.CIR.103.1.108
- Paterno R, Ruocco A, Postiglione A, Hubsch A, Andresen I, Lang MG . Reconstituted high-density lipoprotein exhibits neuroprotection in two rat models of stroke. Cerebrovasc Dis 2004;17:204-211. https://doi.org/10.1159/000075792
- Reuben DB, Ix JH, Greendale GA, Seeman TE. The predictive value of combined hypoalbuminemia and hypocholestrolemia in high functioning community-dwelling older persons: MacArthur Studies of Successfun Aging. J Am Geriatr Soc 1999;47:402-406.
- Partonen T, Haukka J, Virtamo J, Taylor PR, Lonnqvist J. Association of low serum total cholesterol with major depression and suicide. Br J of Psychiatry 1999;175:259-262. https://doi.org/10.1192/bjp.175.3.259
- Colin A, Reggers J, Castronovo V, Ansseau M. [Lipids, depression and suicide]. Encephale 2003;29:49-58.
- Yaffe K, Barrett-Connor E, Lin F, Grady D. Serum lipoprotein levels, statin use, and cognitive function in older women. Arch Neurol 2002;59:378-384. https://doi.org/10.1001/archneur.59.3.378
- Bove M, Carnevali L, Cicero AF, Grandi E, Gaddoni M, Noera G, et al. Psychosocial factors and metabolic parameters: Is there any association in elderly people? The Massa Lombarda Project. Aging Ment Health 2010;9:1-6.
- Song F, Poljak A, Smythe GA, Sachdev P. Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res Rev 2009;61:69-80. https://doi.org/10.1016/j.brainresrev.2009.05.003
- Cramer C, Haan MN, Galea S, Langa KM, Kalbfleisch JD. Use of statin and incidence of dementia and cognitive impairment without dementia in a cohort study. Neurology 2008;71:344-350. https://doi.org/10.1212/01.wnl.0000319647.15752.7b
- Sparks DL, Kryscio RJ, Sabbagh MN, Connor DJ, Sparks LM, Liebsack C. Reduced risk of incident AD with elective statin use in a clinical trial cohort. Curr Alzheimer Res 2008;5:416-421. https://doi.org/10.2174/156720508785132316
- Haag MD, Hofman A, Koudstaal PJ, Stricker BH, Breteler MM. Statins are associated with a reduced risk of Alzheimer's disease regardless of lipophilicity. The Rotterdam Study. J Neurol Neurosurg Psychiatry 2009;80:13-17. https://doi.org/10.1136/jnnp.2008.150433
- Sparks DL, Kryscio RJ, Connor DJ, Sabbagh MN, Sparks LM, Lin Y, et al. Cholesterol and cognitive performance in normal controls and the influence of elective statin use after conversion to mild cognitive impairment: results in a clinical trial cohort. Neurodegener Dis 2010;7:183-186. https://doi.org/10.1159/000295660